Other Versions Sample Clauses

The "Other Versions" clause defines how different versions or editions of a document, agreement, or product are treated under the contract. It typically clarifies whether previous, current, or future versions are included in the scope of the agreement, and may specify which version governs in case of discrepancies. This clause ensures clarity about which version's terms apply, preventing confusion or disputes over outdated or conflicting provisions.
Other Versions. The parties may mutually agree that Licensee submit versions of the Online Features or Licensee Game Servers at stages of development other than as identified above for review and feedback by Microsoft. Such review shall be within the discretion of Microsoft and may require the payment of processing fees by Licensee to offset the costs associated with the review of such Software Titles.
View SourceView Similar (5)
Other Versions. The parties may mutually agree that Licensee submit versions of the Software Title at stages of development other than as identified above for review and feedback by Microsoft. Such review shall be within the discretion of Microsoft and may require the payment of processing fees by Licensee to offset the costs associated with the review of such Software Titles.
View SourceView Similar (3)
Other Versions. Each party acknowledges that the other party may develop and/or distribute translators (or versions of translators) other than those contemplated by this Section 5.3.
View SourceView Similar (2)
Other Versions. Preparing, making, delivering and using foreign, radio, TV, home video or any other media versions of the Picture, or titles thereof, or making changes required by censorship and rating considerations, or for any other purpose.
View SourceView Similar (2)
Other Versions. Dubbing costs incurred to purchase, make, deliver and use French versions of the Company's Properties.
View Source
Other Versions. The right to create other cuts or versions of Productions which have commenced production prior to the expiration of the Production Term, including foreign language versions, television versions, director's cuts, expanded versions (which may include previously deleted scenes), shorter versions, enhanced audio versions, etc., provided that (i) all such versions are fundamentally the same motion picture as a Picture that was produced during the Production Term, (ii) SPE shall not photograph any new footage after the expiration of the Production Term for inclusion in any such version of the Picture and (iii) SPE shall not incorporate into any such version of the Picture any new footage photographed after the expiration of the Production Term.
View Source
Other Versions. Costs and expenses attributable to modifying the Program(s) for any and all uses which may be made of it, including, but not limited to, any costs incurred in retitling the Program(s), removing commercial material, dubbing or subtitling the Program(s) for foreign distribution, or otherwise altering or editing the Program(s) for any uses (whether for censorship purposes or otherwise).
View Source
Other Versions. Subject to Section 13 of the Agreement, costs to make, deliver, and use Foreign audiovisual cassettes, discs, or any similar devices, or any other media versions of the Picture, or the titles thereof, or to make changes required by censorship or rating considerations, to the extent not included in the Cost of Production.
View Source

Related to Other Versions

  • Other Uses Even if Customer opts out of PEP, the Software monitors, records, and reports to Sage information about the installation and use of the Software, including, but not limited to, information about Customer’s devices and the frequency, type, and manner of use to which the Software is put. Customer acknowledges that Sage may collect, use, and disclose the information as described in the Sage Privacy Notice posted at ▇▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇/en-us/legal/privacy-and-cookies/ (if you are contracting with Sage Software, Inc.) or ▇▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇/en-ca/legal/privacy-and-cookies/ (if you are contracting with Sage Software Canada Ltd.), or such other URL as Sage may notify Customer of, and as may be described in the user interface associated with the applicable features.

  • Other Users If required by Applicable Laws and Regulations or if the Parties mutually agree, such agreement not to be unreasonably withheld or delayed, to allow one or more Parties to use the Transmission Owner’s Interconnection Facilities, or any part thereof, Interconnection Customer will be entitled to compensation for the capital expenses it incurred in connection with the Interconnection Facilities based upon the pro rata use of the Interconnection Facilities by Transmission Owner, all non-Party users, and Interconnection Customer, in accordance with Applicable Laws and Regulations or upon some other mutually-agreed upon methodology. In addition, cost responsibility for ongoing costs, including operation and maintenance costs associated with the Interconnection Facilities, will be allocated between Interconnection Customer and any non-Party users based upon the pro rata use of the Interconnection Facilities by Transmission Owner, all non-Party users, and Interconnection Customer, in accordance with Applicable Laws and Regulations or upon some other mutually agreed upon methodology. If the issue of such compensation or allocation cannot be resolved through such negotiations, it shall be submitted to Dispute Resolution pursuant to Section 12 of the Tariff.

  • Publicity; Use of Names Neither Party shall use the name, trademark, trade name or logo of the other Party, its Affiliates or their respective employee(s) in any publicity, promotion, news release or disclosure relating to this Agreement or its subject matter, without the prior express written permission of the other Party, except for those disclosures expressly authorized under this Article 4. Following execution of this Agreement, either Party may issue a press release announcing the existence of this Agreement in form and substance agreed to in writing by both Parties, such agreement to not be unreasonably withheld or delayed. Each Party agrees not to issue any other press release or other public statement disclosing other information relating to this Agreement or the transactions contemplated hereby without the prior written consent of the other Party, which consent shall not be unreasonably withheld or delayed; provided that Arvinas agrees that it shall be deemed reasonable for Pfizer to withhold its consent for the disclosure of any information related to a Target or a specific Compound or the amount of any payment made or to be made under this Agreement; and provided further that any disclosure which is required by Law or the rules of a securities exchange, as reasonably advised by the disclosing Party’s counsel, may be made subject to the following. Each Party agrees to provide to the other Party a copy of any public announcement regarding this Agreement or the subject matter thereof as soon as reasonably practicable under the circumstances prior to its scheduled release. Except under extraordinary circumstances or to the extent any such advance notice or notice period is not consistent with applicable Law, each Party shall provide the other with an advance copy of any such announcement at least [**] prior to its scheduled release. Each Party shall have the right to expeditiously review and recommend changes to any such announcement and, except as otherwise required by Law, the Party whose announcement has been reviewed shall remove any information the reviewing Party reasonably deems to be inappropriate for disclosure. The contents of any announcement or similar publicity which has been reviewed and approved by the reviewing Party can be re-released by either Party without a requirement for re-approval. In addition, except to the extent required by Laws in connection with patent enforcement activities conducted in accordance with Article 7, Pfizer shall not use the name “Yale” or “Yale University,” nor any variation or adaptation thereof, nor any trademark, trade name or other designation owned by Yale University, nor the names of any of its trustees, officers, faculty, students, employees or agents, for any purpose without the prior written consent of Yale University in each instance, such consent to be granted or withheld by Yale University in its sole discretion, except that Pfizer may state that it has sublicensed from Yale University one or more of the patents or applications comprising the Yale Licensed Patents.

  • Links to Other Web Sites Our website does contain links to affiliate and other websites. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ does not claim nor accept responsibility for any privacy policies, practices and/or procedures of other such websites. Therefore, we encourage all users and visitors to be aware when they leave our website and to read the privacy statements of each and every website that collects personally identifiable information. The aforementioned Privacy Policy Agreement applies only and solely to the information collected by our website and its licensed agents.

  • Derivative Works Constellation Beers shall acquire no ownership rights in the Licensed Intellectual Property or derivative works based thereon or any intellectual property deemed to be owned by Marcas Modelo or Modelo Group as a result of this Agreement. Constellation Beers shall, at any time requested by Marcas Modelo or Modelo Group, whether during or subsequent to the term hereof, disclaim in writing any such property interest or ownership in the Licensed Intellectual Property.